Results 11 to 20 of about 311,423 (321)

Influenza Hemagglutinin Structures and Antibody Recognition [PDF]

open access: yesCold Spring Harbor Perspectives in Medicine, 2019
Hemagglutinin (HA) is most abundant glycoprotein on the influenza virus surface. Influenza HA promotes viral entry by engaging the receptor and mediating virus-host membrane fusion. At the same time, HA is the major antigen of the influenza virus. HA antigenic shift can result in pandemics, whereas antigenic drift allows human circulating strains to ...
Nicholas C, Wu, Ian A, Wilson
openaire   +3 more sources

Bovine Lactoferrin Prevents Influenza A Virus Infection by Interfering with the Fusogenic Function of Viral Hemagglutinin

open access: yesViruses, 2019
Bovine lactoferrin (bLf) is an iron-binding glycoprotein folded in two symmetric globular lobes (N- and C-lobes) with potent antimicrobial and immunomodulatory activities.
Fabiana Superti   +3 more
doaj   +2 more sources

Self-Assembling Nanoparticle Hemagglutinin Influenza Vaccines Induce High Antibody Response. [PDF]

open access: yesInt J Mol Sci
As a highly pathogenic avian virus, H5 influenza poses a serious threat to livestock, the poultry industry, and public health security. Hemagglutinin (HA) is both the dominant epitope and the main target of influenza-neutralizing antibodies.
Ren H   +8 more
europepmc   +2 more sources

Genetic characterization of a new candidate hemagglutinin subtype of influenza A viruses

open access: yesEmerging Microbes and Infections, 2023
Avian influenza viruses (AIV) have been classified on the basis of 16 subtypes of hemagglutinin (HA) and 9 subtypes of neuraminidase. Here we describe genomic evidence for a new candidate HA subtype, nominally H19, with a large genetic distance to all ...
S. Fereidouni   +7 more
semanticscholar   +1 more source

An influenza hemagglutinin stem nanoparticle vaccine induces cross-group 1 neutralizing antibodies in healthy adults

open access: yesScience Translational Medicine, 2023
Influenza vaccines could be improved by platforms inducing cross-reactive immunity. Immunodominance of the influenza hemagglutinin (HA) head in currently licensed vaccines impedes induction of cross-reactive neutralizing stem-directed antibodies.
A. Widge   +124 more
semanticscholar   +1 more source

Strategies Targeting Hemagglutinin as a Universal Influenza Vaccine

open access: yesVaccines, 2021
Influenza virus has significant viral diversity, both through antigenic drift and shift, which makes development of a vaccine challenging. Current influenza vaccines are updated yearly to include strains predicted to circulate in the upcoming influenza ...
Brianna L. Bullard, E. Weaver
semanticscholar   +1 more source

Prolonged Codelivery of Hemagglutinin and a TLR7/8 Agonist in a Supramolecular Polymer–Nanoparticle Hydrogel Enhances Potency and Breadth of Influenza Vaccination

open access: yesACS Biomaterials Science & Engineering, 2021
The sustained release of vaccine cargo has been shown to improve humoral immune responses to challenging pathogens such as influenza. Extended codelivery of antigen and adjuvant prolongs germinal center reactions, thus improving antibody affinity ...
Gillie A. Roth   +6 more
semanticscholar   +1 more source

Analysis of adaptation mutants in the hemagglutinin of the influenza A(H1N1)pdm09 virus. [PDF]

open access: yesPLoS ONE, 2013
Hemagglutinin is the major surface glycoprotein of influenza viruses. It participates in the initial steps of viral infection through receptor binding and membrane fusion events.
Alicia Jiménez-Alberto   +3 more
doaj   +1 more source

Antivirals Targeting the Surface Glycoproteins of Influenza Virus: Mechanisms of Action and Resistance

open access: yesViruses, 2021
Hemagglutinin and neuraminidase, which constitute the glycoprotein spikes expressed on the surface of influenza A and B viruses, are the most exposed parts of the virus and play critical roles in the viral lifecycle.
Yaqin Bai   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy